scholarly journals 28: Treatment characteristics for children with cystic fibrosis and meconium ileus admitted within the first 14 days of life

2021 ◽  
Vol 20 ◽  
pp. S14-S15
Author(s):  
J. Gonzales Cordova ◽  
J. Slaven ◽  
J. Saunders ◽  
C. Ren ◽  
D. Sanders
1977 ◽  
Vol 72 (4) ◽  
pp. 732-736 ◽  
Author(s):  
John W. Matseshe ◽  
Vay L.W. Go ◽  
Eugene P. DiMagno

2020 ◽  
Vol 109 (12) ◽  
pp. 2738-2739
Author(s):  
Ioanna Loukou ◽  
Maria Moustaki ◽  
Marina Plyta ◽  
Konstantinos Douros

PEDIATRICS ◽  
1991 ◽  
Vol 87 (6) ◽  
pp. 954-955
Author(s):  
IAN C. T. LYON ◽  
DIANNE R. WEBSTER

To the Editor.— The report on newborn screening for cystic fibrosis1 illustrates the need for continued evaluation of such programs. The authors state that the identification of cases of cystic fibrosis (CF) by an elevated level of immunoreactive trypsinogen (IRT) in second (follow-up) samples from infants with positive initial screening tests could result in false negatives in 27% of cases of cystic fibrosis without meconium ileus (MI). We have screened 401 122 infants using the method originally reported.2


The Lancet ◽  
1984 ◽  
Vol 324 (8396) ◽  
pp. 223 ◽  
Author(s):  
Françoise Muller ◽  
JeanChristophe Frot ◽  
MarieCecile Aubry ◽  
Joelle Boue ◽  
André Boue

BMJ ◽  
1983 ◽  
Vol 287 (6390) ◽  
pp. 501-502 ◽  
Author(s):  
P L Zentler-Munro ◽  
M E Hodson ◽  
J C Batten

2015 ◽  
Vol 3 (7) ◽  
pp. 298-300
Author(s):  
Nicole Hooft ◽  
David M. Notrica ◽  
Jae-O. Bae

Sign in / Sign up

Export Citation Format

Share Document